MARYBETH LYNN: Open Payments
NPI 1952171951 · GLEN MILLS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,089 in 52 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,784 · 2025 $1,089
Food & beverage: $1,089
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $318 |
| Axsome Therapeutics, Inc. | 10 | $155 |
| PFIZER INC. | 5 | $104 |
| ABBVIE INC. | 4 | $92 |
| Exact Sciences Corporation | 2 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Alkermes, Inc. | 1 | $33 |
| Almatica Pharma LLC | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
Products named: Wegovy, Auvelity, Ozempic, UBRELVY, PAXLOVID, XIFAXAN, CAPLYTA, VRAYLAR.
Industry payments across PA — which companies pay providers there.
